US FDA declines to approve Corcept's drug for rare hormonal disorder
01.01.2026
By Sneha S K and Sahil Pandey Dec 31 (Reuters) - The U. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal disorder, the company said on Wednesday.